Skip to main content

RenovoRx, Inc.

RNXT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001574094

No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding RenovoRx, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of RNXT: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders1827+9
Shares1.01M10.1M+9.06M (+894.3%)
Value$1.31M$9.98M+$8.67M (+662.7%)

New holders (13)

Institutions that held RenovoRx, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to RNXT in Q1 2025
InstitutionSharesValue% of portfolio
AIGH Capital Management LLC3,467,275$3.43M1.78%
AWM Investment Company, Inc.2,285,000$2.26M0.31%
Alyeska Investment Group, L.P.688,577$681.7K0.00%
Bleichroeder LP500,000$495.0K0.13%
Stonepine Capital Management, LLC278,188$275.4K0.32%
Corsair Capital Management, L.P.187,700$185.8K0.05%
Chicago Partners Investment Group LLC92,356$97.4K0.00%
HighTower Advisors, LLC40,000$39.6K0.00%
Northern Trust Corp26,776$26.5K0.00%
Colony Group, LLC11,000$10.9K0.00%
Brighton Jones LLC10,656$10.6K0.00%
Boston Private Wealth LLC1,094$1.08K0.00%
Barclays PLC43$430.00%

Sold out (4)

Institutions that held RenovoRx, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of RNXT in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Millennium Management LLC76,814$99.1K
Citadel Advisors LLC37,757$48.7K
Two Sigma Securities, LLC11,704$15.1K
Citigroup Inc384$495